Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neocortex | 15 | 2019 | 95 | 3.830 |
Why?
|
| Epilepsy | 22 | 2019 | 395 | 3.240 |
Why?
|
| Electroencephalography | 32 | 2022 | 707 | 2.790 |
Why?
|
| Seizures | 9 | 2023 | 295 | 2.680 |
Why?
|
| Action Potentials | 14 | 2023 | 573 | 1.780 |
Why?
|
| Neurons | 11 | 2023 | 1546 | 1.730 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2022 | 122 | 1.510 |
Why?
|
| Models, Neurological | 17 | 2018 | 405 | 1.500 |
Why?
|
| Signal Processing, Computer-Assisted | 8 | 2023 | 201 | 1.490 |
Why?
|
| Nerve Net | 8 | 2016 | 366 | 1.470 |
Why?
|
| Scalp | 7 | 2021 | 72 | 1.400 |
Why?
|
| Pyramidal Cells | 4 | 2012 | 80 | 1.290 |
Why?
|
| Brain | 10 | 2021 | 2216 | 1.090 |
Why?
|
| Brain Waves | 3 | 2019 | 32 | 0.960 |
Why?
|
| Evoked Potentials | 5 | 2016 | 190 | 0.920 |
Why?
|
| Brain Mapping | 9 | 2010 | 548 | 0.870 |
Why?
|
| Electric Stimulation | 7 | 2016 | 347 | 0.850 |
Why?
|
| Computer Simulation | 14 | 2013 | 1078 | 0.790 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2017 | 42 | 0.700 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 49 | 0.700 |
Why?
|
| Synaptic Transmission | 2 | 2019 | 222 | 0.700 |
Why?
|
| Neurophysiology | 1 | 2018 | 14 | 0.660 |
Why?
|
| Biological Clocks | 2 | 2010 | 74 | 0.620 |
Why?
|
| Hippocampus | 2 | 2021 | 442 | 0.580 |
Why?
|
| Gamma Rhythm | 1 | 2016 | 14 | 0.570 |
Why?
|
| Infant, Newborn | 4 | 2012 | 2378 | 0.500 |
Why?
|
| Patch-Clamp Techniques | 5 | 2016 | 396 | 0.430 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2012 | 87 | 0.410 |
Why?
|
| N-Methylaspartate | 2 | 2010 | 51 | 0.410 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2010 | 45 | 0.410 |
Why?
|
| Cerebral Cortex | 8 | 2010 | 584 | 0.410 |
Why?
|
| Nonlinear Dynamics | 4 | 2018 | 73 | 0.400 |
Why?
|
| Membrane Potentials | 1 | 2012 | 435 | 0.390 |
Why?
|
| Blood Specimen Collection | 1 | 2010 | 27 | 0.380 |
Why?
|
| Sucrose | 1 | 2010 | 64 | 0.380 |
Why?
|
| Sodium Channels | 2 | 2012 | 129 | 0.370 |
Why?
|
| In Vitro Techniques | 5 | 2016 | 989 | 0.370 |
Why?
|
| Analgesia | 1 | 2010 | 57 | 0.370 |
Why?
|
| Humans | 42 | 2023 | 86601 | 0.360 |
Why?
|
| Biomedical Research | 2 | 2010 | 375 | 0.350 |
Why?
|
| Neural Pathways | 2 | 2010 | 308 | 0.350 |
Why?
|
| Algorithms | 12 | 2013 | 1830 | 0.350 |
Why?
|
| Child | 18 | 2016 | 6926 | 0.340 |
Why?
|
| Child, Preschool | 7 | 2016 | 3611 | 0.310 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 2232 | 0.300 |
Why?
|
| Respiration | 1 | 2008 | 262 | 0.300 |
Why?
|
| Animals | 19 | 2016 | 26581 | 0.290 |
Why?
|
| Heart Rate | 1 | 2008 | 492 | 0.280 |
Why?
|
| Tetrodotoxin | 3 | 2012 | 50 | 0.280 |
Why?
|
| Adolescent | 13 | 2016 | 8979 | 0.270 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2005 | 87 | 0.260 |
Why?
|
| Biophysics | 3 | 2016 | 152 | 0.260 |
Why?
|
| Epilepsies, Partial | 2 | 2017 | 42 | 0.250 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2004 | 17 | 0.240 |
Why?
|
| Epilepsy, Absence | 1 | 2003 | 8 | 0.240 |
Why?
|
| Female | 23 | 2018 | 44507 | 0.220 |
Why?
|
| Amplifiers, Electronic | 1 | 2022 | 6 | 0.220 |
Why?
|
| Feedback | 1 | 2023 | 133 | 0.210 |
Why?
|
| Mice, Inbred Strains | 2 | 2012 | 307 | 0.210 |
Why?
|
| Programming Languages | 2 | 2013 | 15 | 0.200 |
Why?
|
| Periodicity | 2 | 2012 | 119 | 0.200 |
Why?
|
| Male | 19 | 2016 | 40956 | 0.190 |
Why?
|
| Electrocorticography | 1 | 2019 | 37 | 0.170 |
Why?
|
| Patient Discharge | 1 | 2021 | 300 | 0.160 |
Why?
|
| Mice | 6 | 2012 | 11352 | 0.160 |
Why?
|
| Microelectrodes | 1 | 2016 | 81 | 0.140 |
Why?
|
| Animals, Newborn | 3 | 2012 | 510 | 0.140 |
Why?
|
| Spectrum Analysis | 1 | 2016 | 118 | 0.140 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 207 | 0.140 |
Why?
|
| Drug Combinations | 1 | 2016 | 224 | 0.130 |
Why?
|
| Neurotransmitter Agents | 1 | 2016 | 106 | 0.130 |
Why?
|
| Oscillometry | 1 | 2014 | 25 | 0.130 |
Why?
|
| Vagus Nerve | 1 | 2014 | 45 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2018 | 572 | 0.120 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2014 | 9 | 0.120 |
Why?
|
| Diagnostic Imaging | 2 | 2010 | 469 | 0.120 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2014 | 21 | 0.120 |
Why?
|
| Rats | 3 | 2016 | 3990 | 0.120 |
Why?
|
| Deep Brain Stimulation | 1 | 2014 | 54 | 0.120 |
Why?
|
| Anticonvulsants | 1 | 2014 | 126 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1219 | 0.110 |
Why?
|
| Young Adult | 2 | 2018 | 5974 | 0.110 |
Why?
|
| Kv1.4 Potassium Channel | 1 | 2012 | 1 | 0.110 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2012 | 5 | 0.110 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2012 | 7 | 0.110 |
Why?
|
| Skull | 4 | 2010 | 249 | 0.110 |
Why?
|
| Sodium Channel Blockers | 1 | 2012 | 27 | 0.110 |
Why?
|
| Potassium Channel Blockers | 1 | 2012 | 64 | 0.110 |
Why?
|
| Biophysical Phenomena | 1 | 2012 | 120 | 0.110 |
Why?
|
| Hallucinations | 1 | 2011 | 27 | 0.100 |
Why?
|
| Magnesium | 1 | 2012 | 177 | 0.100 |
Why?
|
| Magnetoencephalography | 1 | 2011 | 20 | 0.100 |
Why?
|
| Linear Models | 2 | 2011 | 421 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 114 | 0.100 |
Why?
|
| Infant | 4 | 2012 | 3045 | 0.100 |
Why?
|
| Recurrence | 1 | 2014 | 1139 | 0.100 |
Why?
|
| Potassium | 1 | 2012 | 281 | 0.100 |
Why?
|
| Sodium | 1 | 2012 | 341 | 0.100 |
Why?
|
| Orientation | 1 | 2011 | 119 | 0.100 |
Why?
|
| Adaptation, Biological | 1 | 2011 | 85 | 0.100 |
Why?
|
| Flavoproteins | 1 | 2010 | 25 | 0.100 |
Why?
|
| Electrophysiology | 3 | 2006 | 401 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2818 | 0.100 |
Why?
|
| Fourier Analysis | 1 | 2010 | 125 | 0.100 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2010 | 78 | 0.090 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 217 | 0.090 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2010 | 32 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2010 | 248 | 0.090 |
Why?
|
| Stochastic Processes | 1 | 2010 | 74 | 0.090 |
Why?
|
| Models, Biological | 3 | 2013 | 1749 | 0.090 |
Why?
|
| Anesthetics, Local | 1 | 2010 | 76 | 0.090 |
Why?
|
| Olfactory Mucosa | 2 | 1982 | 33 | 0.090 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2009 | 7 | 0.090 |
Why?
|
| Alligators and Crocodiles | 2 | 1982 | 20 | 0.090 |
Why?
|
| Songbirds | 1 | 2010 | 83 | 0.090 |
Why?
|
| Reptiles | 2 | 1982 | 37 | 0.090 |
Why?
|
| Software | 1 | 2013 | 654 | 0.090 |
Why?
|
| Spinal Cord | 1 | 2010 | 249 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2012 | 447 | 0.090 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2012 | 332 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2010 | 684 | 0.080 |
Why?
|
| Visual Cortex | 1 | 2011 | 251 | 0.080 |
Why?
|
| Models, Cardiovascular | 1 | 2008 | 98 | 0.080 |
Why?
|
| Synapses | 2 | 2010 | 265 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2011 | 482 | 0.080 |
Why?
|
| Electrodes | 2 | 2009 | 78 | 0.080 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2007 | 8 | 0.080 |
Why?
|
| Electrodes, Implanted | 5 | 2009 | 171 | 0.080 |
Why?
|
| Noise | 1 | 2007 | 27 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2012 | 912 | 0.070 |
Why?
|
| Research Design | 1 | 2010 | 594 | 0.070 |
Why?
|
| Riluzole | 1 | 2006 | 15 | 0.070 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2007 | 64 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 864 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2007 | 1204 | 0.070 |
Why?
|
| Gap Junctions | 1 | 2006 | 142 | 0.070 |
Why?
|
| Time Factors | 3 | 2012 | 5209 | 0.070 |
Why?
|
| Monitoring, Physiologic | 1 | 2007 | 268 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 297 | 0.060 |
Why?
|
| Sensory Receptor Cells | 2 | 1982 | 35 | 0.060 |
Why?
|
| Biological Evolution | 1 | 2011 | 918 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 579 | 0.060 |
Why?
|
| Odorants | 2 | 1982 | 70 | 0.060 |
Why?
|
| Acoustic Stimulation | 1 | 2004 | 130 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2012 | 2705 | 0.060 |
Why?
|
| Functional Laterality | 1 | 2004 | 201 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 307 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2003 | 596 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 1673 | 0.050 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2012 | 39 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2014 | 7988 | 0.050 |
Why?
|
| Jaw | 1 | 1982 | 61 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2004 | 459 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2012 | 1990 | 0.050 |
Why?
|
| Sleep | 2 | 2018 | 444 | 0.050 |
Why?
|
| Adult | 2 | 2018 | 25640 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 3352 | 0.040 |
Why?
|
| Finite Element Analysis | 2 | 2006 | 74 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2600 | 0.030 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2012 | 5 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2012 | 135 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 1718 | 0.030 |
Why?
|
| Oxidants | 1 | 2012 | 86 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 158 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2012 | 297 | 0.030 |
Why?
|
| Bicuculline | 1 | 2010 | 18 | 0.020 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2010 | 15 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 242 | 0.020 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2010 | 5 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 1 | 2011 | 151 | 0.020 |
Why?
|
| Prosencephalon | 1 | 2010 | 62 | 0.020 |
Why?
|
| Dura Mater | 1 | 2010 | 44 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2010 | 91 | 0.020 |
Why?
|
| Markov Chains | 1 | 2010 | 125 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2010 | 97 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 2009 | 66 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2010 | 130 | 0.020 |
Why?
|
| Vocalization, Animal | 1 | 2010 | 100 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2010 | 303 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2010 | 117 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2010 | 172 | 0.020 |
Why?
|
| Piperazines | 1 | 2010 | 272 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 751 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1961 | 0.020 |
Why?
|
| Electricity | 1 | 2007 | 23 | 0.020 |
Why?
|
| Learning | 1 | 2010 | 280 | 0.020 |
Why?
|
| Insulin | 1 | 2012 | 1160 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2006 | 51 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2006 | 91 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2005 | 144 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2007 | 394 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2006 | 574 | 0.010 |
Why?
|
| Masticatory Muscles | 1 | 1982 | 19 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 3092 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 1034 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1565 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 3674 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 2501 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 1982 | 324 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1982 | 666 | 0.010 |
Why?
|
| Anura | 1 | 1978 | 19 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1997 | 90 | 0.010 |
Why?
|
| Craniotomy | 1 | 1997 | 88 | 0.010 |
Why?
|
| Mandible | 1 | 1977 | 119 | 0.010 |
Why?
|